Product Information
IMIPRAMINE HCL 25 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0912 per EA under NDC 64380017001. Its NADAC has been published 216 times since Jul 6, 2022.
FDA first approved this application on Oct 21, 1983. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380017001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA088262FDA Approved
10/21/1983
TE Code
AB
On Market Since
5/9/2022
Pharmacological Classes
Price Statistics
The NADAC for IMIPRAMINE HCL 25 MG TABLET has been published 216 times since Jul 6, 2022, and over the history we have for it it has declined 3.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0912 per EA |
|---|---|
| All-time high | $0.1055 (Dec 13, 2023) |
| All-time low | $0.0746 (Nov 20, 2024) |
| 52-week high | $0.0912 |
| 52-week low | $0.0806 |
| Median price | $0.0911 |
| Average price | $0.0908 |
| Largest weekly change | +27.4% (Mar 20, 2024) |
| Weeks tracked | 216 |
| Tracking since | Jul 6, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IMIPRAMINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IMIPRAMINE HCL 25 MG TABLET, manufactured by Strides Pharma Inc., is $0.0912 per EA (NDC 64380017001), effective Aug 19, 2026.
How has the price of IMIPRAMINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for IMIPRAMINE HCL 25 MG TABLET has declined 3.2%. It has been tracked across 216 weekly CMS publications since Jul 6, 2022.
What are the highest and lowest recorded NADAC prices for IMIPRAMINE HCL 25 MG TABLET?
Since Jul 6, 2022, the NADAC for IMIPRAMINE HCL 25 MG TABLET has ranged from a low of $0.0746 (Nov 20, 2024) to a high of $0.1055 (Dec 13, 2023), with a median of $0.0911 per EA.
Are there cheaper alternatives to IMIPRAMINE HCL 25 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IMIPRAMINE HCL 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures IMIPRAMINE HCL 25 MG TABLET?
IMIPRAMINE HCL 25 MG TABLET (NDC 64380017001) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.